Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus BevacizumabTaito Fukushima, Shin Maeda, Satoshi Kobayashi et al.|The Oncologist|2023Cited by 42